Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 700 | 541 | 2,463 | 2,214 |
| Receivables | 127 | 98 | 52 | 517 |
| Other current assets | 41 | 1,229 | 54 | 19 |
| TOTAL | $1,634 | $1,982 | $2,692 | $2,836 |
| Non-Current Assets | ||||
| PPE Net | 807 | 188 | 102 | 0 |
| TOTAL | $807 | $188 | $102 | $0 |
| Total Assets | $2,441 | $2,170 | $2,794 | $2,836 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | N/A | 1,043 |
| Accrued Expenses | 339 | 548 | 456 | 183 |
| Other current liabilities | N/A | 1,197 | N/A | 242 |
| TOTAL | $398 | $1,908 | $583 | $1,631 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 0 | 95 | N/A | N/A |
| Other Non-Current Liabilities | 78 | 71 | 95 | 28 |
| TOTAL | $282 | $73 | $115 | $28 |
| Total Liabilities | $680 | $1,981 | $698 | $1,659 |
| Shareholders' Equity | ||||
| Retained earnings | -19,100 | -14,057 | -10,418 | -2,249 |
| Other shareholders' equity | 1,395 | 2,084 | 1,264 | 169 |
| TOTAL | $1,761 | $189 | $2,096 | $1,177 |
| Total Liabilities And Equity | $2,441 | $2,170 | $2,794 | $2,836 |